Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women

AIDS Research and Human Retroviruses

Volumn 27, Issue 11, 2011, Pages 1149-1155

  Dao, Christine N ^a   Peters, Philip J ^a   Kiarie, James N ^b   Zulu, Isaac ^c   Muiruri, Peter ^b   Ong'Ech, John ^b   Mutsotso, Winfred ^d   Potter, Dara ^c   Njobvu, Lungowe ^e,f   Stringer, Jeffrey S A ^e,f   Borkowf, Craig B ^a   Bolu, Omotayo ^g   Weidle, Paul J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYATTA NATIONAL HOSPITAL   (Kenya)

^c CDC Zambia   (Zambia)

^d Centers for Disease Control and Prevention Kenya   (Kenya)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHLORIDE; SODIUM;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CD4 LYMPHOCYTE COUNT; CHLORIDE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOALBUMINEMIA; HYPOCHLOREMIA; HYPONATREMIA; KENYA; MAJOR CLINICAL STUDY; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SODIUM BLOOD LEVEL; TUBERCULOSIS; ZAMBIA;

ADULT; ANTI-HIV AGENTS; CAUSE OF DEATH; CHLORIDES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; HYPOALBUMINEMIA; HYPONATREMIA; KENYA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS; SERUM ALBUMIN; SODIUM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ZAMBIA;

EID: 80655144917     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0345     Document Type: Article

References (34)

1. WHO. Antiretroviral Therapy for HIV Infection in Adult and Adolescents in Resource-Limited Settings: Towards Universal Access. WHO, Geneva, 2009. Available at http://www.who.int/hiv/pub/2009progressreport/en/index.html. Accessed November 3, 2009.
2. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 2009;367: 817-824.
3. Castelnuovo B, Manabe YC, Kiragga A, et al.: Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after anti-retroviral therapy initiation in an urban African cohort. Clin Infect Dis 2009;49(6):965-972.
4. Lawn SD, Myer L, Orrell C, Bekker LG, and Wood R: Early mortality among adults accessing a community-based anti-retroviral service in South Africa: Implications for programme design. AIDS 2005;19(18):2141-2148. (Pubitemid 41669003)
5. Madec Y, Szumilin E, Genevier C, et al.: Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: Evidence from two developing countries. AIDS 2009;23(7):853-861.
6. Moh R, Danel C, Messou E, et al.: Incidence and determinants of mortality and morbidity following early anti-retroviral therapy initiation in HIV-infected adults in West Africa. AIDS 2007;21(18):2483-2491. (Pubitemid 350145180)
7. Stringer JS, Zulu I, Levy J, et al.: Rapid scale-up of anti-retroviral therapy at primary care sites in Zambia: Feasibility and early outcomes. JAMA 2006;296(7):782-793. (Pubitemid 44223102)
8. Grinsztejn B, Veloso VG, Friedman RK, et al.: Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 2009;23(16):2107-2114.
9. Tuboi SH, Schechter M, McGowan CC, et al.: Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr 2009;51(5):615-623.
10. Zachariah R, Fitzgerald M, Massaquoi M, et al.: Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006;20(18):2355-2360. (Pubitemid 44789538)
11. Lawn SD, Harries AD, and Wood R: Strategies to reduce early morbidity and mortality in adults receiving anti-retroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010;5:18-26.
12. Bonarek M, Morlat P, Chene G, et al.: Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. Int J STD AIDS 2001;12(4):239-244. (Pubitemid 32291613)
13. Graham SM, Baeten JM, Richardson BA, et al.: A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression. AIDS Res Hum Retroviruses 2007; 23(10):1197-1200. (Pubitemid 350014771)
14. Shah S, Smith CJ, Lampe F, et al.: Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: Relationships with gender. HIV Med 2007;8(1):38-45. (Pubitemid 46117840)
15. Tang WW, Kaptein EM, Feinstein EI, and Massry SG: Hy-ponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med 1993;94(2):169-174. (Pubitemid 23046442)
16. Vitting KE, Gardenswartz MH, Zabetakis PM, et al.: Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 1990;263(7):973-978. (Pubitemid 20061543)
17. WHO: The Maputo Declaration on Strengthening of Laboratory Systems. 2008. Available at http://www.who.int/diagnostics-oratory/Maputo-Declaration-2008. pdf. Accessed February 25, 2010.
18. Gershy-Damet GM, Rotz P, Cross D, et al.: The World Health Organization African region laboratory accreditation process: Improving the quality of laboratory systems in the African region. Am J Clin Pathol 2010;134(3):393-400.
19. Mulenga LB, Kruse G, Lakhi S, et al.: Baseline renal insufficiency and risk of death among HIV-infected adults on an-tiretroviral therapy in Lusaka, Zambia. AIDS 2008;22(14): 1821-1827.
20. Stringer J, McConnell M, Kiarie J, et al.: Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based anti-retroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: A multi-country, prospective cohort study. PLoS Med 2010;7(2):e1000233.
21. NIH Division of Acquired Immune Deficiency Syndrome: Division of AIDS Tables for Grading the Severity of Adult and Pediatric Adverse Events. 2004. Available at http://www3.niaid.nih.gov/LabsAndResources/resources/DAID SClinRsrch/PDF/DAIDSAEGradingTable.pdf. Accessed February 9, 2009.
22. Feldman JG, Burns DN, Gange SJ, et al.: Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 2000;14(7):863-870. (Pubitemid 30303464)
23. Story DA, Morimatsu H, Egi M, and Bellomo R: The effect of albumin concentration on plasma sodium and chloride measurements in critically ill patients. Anesth Analg 2007; 104(4):893-897. (Pubitemid 46548317)
24. Glassock R, Cohen A, Danovitch G, and Parsa K: Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med 1990;112(1):35-49. (Pubitemid 20026367)
25. Perazella MA and Brown E: Electrolyte and acid-base disorders associated with AIDS: An etiologic review. J Gen Intern Med 1994;9:232-236. (Pubitemid 24126164)
26. Cusano AJ, Thies HL, Siegal FP, Dreisbach AW, and Mae-saka JK: Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990; 3:949-953. (Pubitemid 20330686)
27. Ellison D and Berl T: The syndrome of inappropriate anti-diuresis. N Engl J Med 2007;356:2064-2072.
28. Cockcroft D, Donevan R, Copland G, and Ibbott J: Military tuberculosis presenting with hyponatremia and thrombo-cytopenia. Can Med Assoc J 1976;115(9):871-873.
29. Lee P and Ho K: Hyponatremia in pulmonary TB: Evidence of ectopic antidiuretic hormone production. Chest 2010; 137(1):207-208.
30. Cain K, McCarthy K, Heilig C, et al.: An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010;362(8):707-716.
31. Wood R, Middelkoop K, Myer L, et al.: Undiagnosed tuberculosis in a community with high HIV prevalence. Am J Respir Crit Care Med 2007;175:87-93.
32. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al.: Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007;298(16):1888-1899. (Pubitemid 350005233)
33. French N, Gray K, Watera C, et al.: Crytococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002;16: 1031-1038. (Pubitemid 34499426)
34. Liechty CA, Solberg P, Were W, et al.: Asymptomatic serum cryptococcal antigenemia and early mortality during anti-retroviral therapy in rural Ugana. Trop Med Int Health 2007;12(8):929-935 (Pubitemid 47245826)